Guangbo Kang
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Biomedical Engineering
- Oncology
- Genetics
- Topics
- Gut microbiota and health (13 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Probiotics and Fermented Foods (4 papers)
In The Last Decade
Guangbo Kang
33 papers receiving 795 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 466
- Radiology, Nuclear Medicine and Imaging 156
- Biomedical Engineering 115
- Oncology 96
- Genetics 84
Countries citing papers authored by Guangbo Kang
This map shows the geographic impact of Guangbo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangbo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangbo Kang more than expected).
Fields of papers citing papers by Guangbo Kang
This network shows the impact of papers produced by Guangbo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangbo Kang. The network helps show where Guangbo Kang may publish in the future.
Co-authorship network of co-authors of Guangbo Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Guangbo Kang. A scholar is included among the top collaborators of Guangbo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangbo Kang. Guangbo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 22 | |
| 10 | 24 | |
| 11 | 5 | |
| 12 | 20 | |
| 13 | 14 | |
| 14 | 15 | |
| 15 | 14 | |
| 16 | 17 | |
| 17 | 46 | |
| 18 | 27 | |
| 19 | 14 | |
| 20 | 36 |
About Guangbo Kang
Guangbo Kang is a scholar working on Biotechnology, Molecular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 802 indexed citations. Recurring topics across this work include Gut microbiota and health (13 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Probiotics and Fermented Foods (4 papers). The work is most often cited by research in Molecular Medicine (45 citations), Biotechnology (61 citations) and Molecular Biology (466 citations). Guangbo Kang has collaborated with scholars based in China, Slovenia and Canada. Frequent co-authors include He Huang, Mengxue Gao, Lina Wang, Xiaocang Cao, Jiewen Wang, Min Hu, Ario de Marco, Xiaoming Cheng, Xiaobo Li and Liang Bai. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.